PURA VIDA INVESTMENTS, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
PURA VIDA INVESTMENTS, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,397,000
+95.4%
20,000
+310.5%
0.08%
+211.5%
Q4 2021$715,000
-73.1%
4,872
-67.5%
0.03%
-67.9%
Q3 2021$2,654,000
-58.4%
15,000
-62.0%
0.08%
-59.3%
Q2 2021$6,384,000
+23.2%
39,522
+30.7%
0.20%
+34.5%
Q1 2021$5,180,000
+135.9%
30,242
+202.4%
0.15%
+85.0%
Q4 2020$2,196,000
-43.6%
10,000
-80.0%
0.08%
-88.0%
Q3 2019$3,896,000
+65.4%
50,0000.0%0.67%
+34.5%
Q3 2018$2,355,00050,0000.50%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders